|
6160
|
Beigene Ltd
|
5.44%
|
HK
|
HK
|
|
EXEL
|
Exelixis, Inc.
|
4.42%
|
US
|
NASDAQ
|
|
MRNA
|
Moderna, Inc.
|
4.40%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.28%
|
US
|
NASDAQ
|
|
ROG
|
Roche Holding AG
|
4.28%
|
CH
|
SW
|
|
BPMC
|
Blueprint Medicines Corporation
|
4.26%
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
4.12%
|
DK
|
CO
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
4.11%
|
US
|
NASDAQ
|
|
VIR
|
Vir Biotechnology, Inc.
|
4.10%
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
3.93%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
3.84%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
2.99%
|
US
|
NASDAQ
|
|
DNA
|
Ginkgo Bioworks Holdings, Inc.
|
2.82%
|
US
|
NYSE
|
|
TWST
|
Twist Bioscience Corporation
|
2.73%
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
2.54%
|
US
|
NASDAQ
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
2.39%
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
2.09%
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
1.77%
|
US
|
NASDAQ
|
|
RCUS
|
Arcus Biosciences, Inc.
|
1.69%
|
US
|
NYSE
|
|
CHRS
|
Coherus BioSciences, Inc.
|
1.37%
|
US
|
NASDAQ
|